Company: MBIO
Filing Date: 2025-03-03
Form Type: DEF 14C
Source: 0001104659-25-019831
Chunk: 2

Company: MUSTANG BIO, INC.
Filing Date: 2025-03-03
Form: DEF 14C
Chunk 2
---
) OF
THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED</div>

This Information Statement
(this “Information Statement”) is being mailed to the holders of record at the close of business on February 19, 2025 (the
“Record Date”) of the shares of common stock, par value $0.0001 per share, of the Company, in connection with the actions
taken by written consent of the Majority Holders in lieu of a meeting to approve the actions described in this Information Statement.

The Majority Holders, beneficially
owning 131,052 shares of our issued and outstanding common stock and 250,000 shares of our issued and outstanding Class A Preferred Stock,
have executed the Written Consent approving the Warrant Share Issuance. The Majority Holders held of record on the Record Date approximately
56% of the voting power necessary to approve the proposed Warrant Share Issuance. Dissenting stockholders do not have any statutory appraisal
rights as a result of the actions taken. The Board does not intend to solicit any proxies or consents from any other stockholders in connection
with this action. All necessary corporate approvals have been obtained, and this Information Statement is furnished solely to advise stockholders
of the action taken by the Written Consent.

Section 228 of the DGCL generally
provides in substance that unless a company’s certificate of incorporation provides otherwise, stockholders may take any action
without a meeting of stockholders, without prior notice and without a vote if a consent or consents in writing, setting forth the action
so taken, is signed by holders of the outstanding stock having not less than the minimum number of votes that would be necessary to authorize
and take such action at a meeting at which all shares entitled to vote thereon were present voted. In order to eliminate the costs and
management time involved in obtaining proxies and to effect the above action as early as possible in order to accomplish the purposes
of the Company as herein described, the Board determined to pursue stockholder action by written consent and successfully obtained written
consent of the Majority Holders.

This Information Statement
is being distributed pursuant to the requirements of the Exchange Act to our stockholders of record on the Record Date. The Warrant Share
Issuance will not become effective before the date which is 20 days after this Information Statement is first mailed to our stockholders.
The 20-day period is expected to conclude on or about March 23,
2025.

The entire